Saturday, June 19, 2021
Home Tags MCN-04-October-2020

MCN-04-October-2020 Related News

Addiction, education, and the future of cannabis policy in the US

Addiction, education, and the future of cannabis policy

Cannabis specialist Dr Peter Grinspoon explores education and policy in US addiction treatment. Dr Peter Grinspoon is a primary care physician, an instructor at Harvard...
Cannabis and hemp in the UK

Cannabis and hemp in the UK

Tim Henley, Director of the Cannabis Trades Association, speaks with MCN Quarterly about hemp and cannabis regulation, policy, and healthcare in the UK. The Cannabis...
Cannabis and chronic pain in Australia

Cannabis and chronic pain in Australia

Painaustralia tells MCN Quarterly about the use of cannabis to treat chronic pain. Despite making up around 60% to 70% of the customer base for...
Medical Cannabis Network Quarterly Issue 4

Medical Cannabis Network Quarterly Issue 4

Welcome to the fourth edition of Medical Cannabis Network Quarterly, which examines the evolution of the cannabis industry in the face of shifting legislation,...
Medical cannabis: science and risk-based methodology

Medical cannabis: science and risk-based methodology

Independent consultancy NNE and venture advisory firm Volvér showcase the significance of science and risk in devising a manufacturing facility. How can cannabis producers bring...
A resource-efficient cannabis industry starts with benchmarking

A resource-efficient cannabis industry starts with benchmarking

Resource Innovation Institute Executive Director Derek Smith highlights the importance of tracking resource consumption in cannabis production. As the global COVID-19 pandemic provides a window...
People of colour must be represented across the cannabis industry

People of colour must be represented across the cannabis industry

There is a renewed reckoning about the exclusion of women and people of colour from power and resources worldwide. The cannabis industry is no exception...
Cannabis cultivation research and data

Cannabis cultivation research and data

The International Cannabis Cultivation Questionnaire aims to develop a better understanding of patterns in small-scale cannabis production. The Global Cannabis Cultivation Research Consortium (GCCRC) is...
Cloud 9 Switzerland Group: nutraceuticals and pharmaceuticals

Cloud 9 Switzerland Group: nutraceuticals and pharmaceuticals

Life sciences company Cloud 9 Switzerland prioritises patient wellbeing, product quality and innovation in clinical practice. Cloud 9 Switzerland is a life sciences company offering...
The full spectrum politics of hemp in Ireland

The full spectrum politics of hemp in Ireland

Chris Allen, Executive Director of Hemp Federation Ireland, tells MCN about the Irish hemp industry. Founded at the Humanities Institute, University College Dublin (UCD) in...
Translating medicinal cannabis regulation into a patient-centred science

Translating medicinal cannabis regulation into a patient-centred science

The Malta Medicines Authority is steering standards of good practice into day-to-day excellence, regulating medicinal cannabis through an approach that upholds scientific quality, innovative...
The Valens Company explore the importance of edibles testing

The Valens Company explore the importance of edibles testing

Jeff Fallows, President of The Valens Company, explores the need for product standardisation in a uniquely challenging market. By 2022, the global worth of the...
Hemp and Novel Foods in Europe

Hemp and Novel Foods in Europe

European Industrial Hemp Association Managing Director Lorenza Romanese tells MCN about Novel Foods legislation and industrial hemp in the EU. The European Industrial Hemp Association...
Cannabis regulation and policy in Australia

Cannabis regulation and policy in Australia

MCN speaks with Australia’s Therapeutic Goods Administration about medical cannabis regulation and access. The Australian Therapeutic Goods Administration (TGA), which operates under the aegis of...
Working towards fair, humanised policy on drugs with ENCOD

Working towards fair, humanised policy on drugs with ENCOD

MCN speaks to Maja Kohek of the European Coalition for Just and Effective Drug Policies about education, policy and harm reduction. The European Coalition for...
Exploring real world applications of cannabis

Exploring real world applications of cannabis

Dr Hance Clarke tells MCN about the Medical Cannabis Real-World Evidence clinical trial. Dr Hance Clarke, MSc, MD, PhD, FRCPC is the Medical Director of...
Medical cannabis in Colombia: the law and the future

Medical cannabis in Colombia: the law and the future

Medical cannabis expert Dr Sandra Carrillo details the history and future of medical cannabis in Colombia. Dr Sandra Carrillo is a medical doctor and renowned...
Shaping future cannabis strategy at the GCI Europe Summit

Shaping future cannabis strategy at the GCI Europe Summit

GCI’s Cannabis Leaders’ Summit goes virtual for 2020. The Global Cannabis Intelligence (GCI) Europe Summit will give global leaders the opportunity to network with the...
Exploring Dutch medical cannabis with Bedrocan

Exploring Dutch medical cannabis with Bedrocan

Ole Heil of Bedrocan, the world’s most experienced legal medical cannabis producer, tells MCN about medical cannabis in the Netherlands. Bedrocan, the sole supplier of...
Novel Foods and the uncertain future of Europe’s hemp industry

Novel Foods and the uncertain future of Europe’s hemp industry

New Frontier Data explores the potential implications of changes to the EU’s Novel Foods legislation. In July 2020, news broke that the European Commission was...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest